SCHEMBL7984482

SCHEMBL7984482

Oc1nc(-c2ccccc2F)nc2ncn(CCOc3ccccc3)c12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
CNOT7 Q9UIV1 1/20 0.41
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
LTA4H P09960 4/20 0.38
SMN1; SMN2 Q16637 5/20 0.36
HTT P42858 2/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
GAA P10253 1/20 0.36
CYP2C9 P11712 1/20 0.36
HPGD P15428 1/20 0.36
CYP2C19 P33261 1/20 0.36
KMT2A Q03164 1/20 0.36
LMNA P02545 1/20 0.35
ALOX15 P16050 1/20 0.35
TSHR P16473 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
CPT2 P23786 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985446 0.94 GBA1 (0.41) GBA1L3MBTL1CNOT7NPC1RAB9A
SCHEMBL7974276 0.84 HTT (0.39) CNOT7HTTALDH1A1
SCHEMBL7984465 0.82 CNOT7 (0.41) CNOT7ALDH1A1LMNATSHR
SCHEMBL7974646 0.81 MAPK14 (0.47) CNOT7SMN1; SMN2MEN1ALDH1A1GAA
SCHEMBL7973917 0.79 LMNA (0.40) ALDH1A1LMNARXFP1
SCHEMBL7988184 0.77 MET (0.42) L3MBTL1SMN1; SMN2HTTMEN1ALDH1A1
SCHEMBL7985870 0.77 GAA (0.50) L3MBTL1ALDH1A1GAAHPGDKMT2A
SCHEMBL7985772 0.77 L3MBTL1 (0.45) L3MBTL1CNOT7NPC1RAB9ALTA4H
SCHEMBL7984480 0.76 CNOT7 (0.47) L3MBTL1CNOT7NPC1RAB9ALTA4H
SCHEMBL7974060 0.76 SMN1; SMN2 (0.41) L3MBTL1NPC1RAB9ASMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed